John Kolbe

6.9k total citations
117 papers, 3.6k citations indexed

About

John Kolbe is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, John Kolbe has authored 117 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 37 papers in Physiology and 11 papers in Oncology. Recurrent topics in John Kolbe's work include Asthma and respiratory diseases (29 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers) and Cystic Fibrosis Research Advances (22 papers). John Kolbe is often cited by papers focused on Asthma and respiratory diseases (29 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers) and Cystic Fibrosis Research Advances (22 papers). John Kolbe collaborates with scholars based in New Zealand, United Kingdom and Australia. John Kolbe's co-authors include Wendy Fergusson, Jeffrey Garrett, Pamela Young, T Eaton, Christopher Lewis, H H Rea, Irene Zeng, Marina Vamos, Diana Bilton and Athol U. Wells and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cochrane Database of Systematic Reviews and Journal of Applied Physiology.

In The Last Decade

John Kolbe

113 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Kolbe New Zealand 37 2.6k 1.2k 345 340 195 117 3.6k
Brian Tiep United States 20 3.2k 1.3× 1.8k 1.5× 174 0.5× 293 0.9× 222 1.1× 49 4.2k
Tomas Eagan Norway 31 2.0k 0.8× 1.1k 0.9× 173 0.5× 282 0.8× 244 1.3× 125 3.1k
Suzanne C. Lareau United States 23 2.5k 1.0× 740 0.6× 360 1.0× 243 0.7× 232 1.2× 45 3.2k
Charlotte Suppli Ulrik Denmark 36 2.8k 1.1× 2.6k 2.1× 413 1.2× 364 1.1× 474 2.4× 232 4.6k
Anders Løkke Denmark 24 1.7k 0.7× 864 0.7× 214 0.6× 347 1.0× 254 1.3× 176 2.4k
G H Koëter Netherlands 26 1.8k 0.7× 1.3k 1.1× 325 0.9× 168 0.5× 445 2.3× 53 2.9k
Alan Crockett Australia 25 1.6k 0.6× 705 0.6× 216 0.6× 198 0.6× 338 1.7× 91 2.4k
David M. Orenstein United States 36 2.8k 1.1× 568 0.5× 255 0.7× 384 1.1× 225 1.2× 119 4.2k
Vicente Plaza Spain 38 3.6k 1.4× 3.4k 2.7× 323 0.9× 253 0.7× 237 1.2× 243 5.1k
Fulvio Braido Italy 33 1.9k 0.7× 2.3k 1.9× 227 0.7× 193 0.6× 157 0.8× 180 4.2k

Countries citing papers authored by John Kolbe

Since Specialization
Citations

This map shows the geographic impact of John Kolbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kolbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kolbe more than expected).

Fields of papers citing papers by John Kolbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kolbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kolbe. The network helps show where John Kolbe may publish in the future.

Co-authorship network of co-authors of John Kolbe

This figure shows the co-authorship network connecting the top 25 collaborators of John Kolbe. A scholar is included among the top collaborators of John Kolbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kolbe. John Kolbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sexton, Paul, et al.. (2013). Fixed Airflow Obstruction among Nonsmokers with Asthma:A Case-Comparison Study. Journal of Asthma. 50(6). 606–612. 7 indexed citations
2.
Sexton, Paul, Peter Black, Lian Wu, et al.. (2013). Chronic Obstructive Pulmonary Disease in Non-smokers: A Case-Comparison Study. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(1). 2–9. 7 indexed citations
3.
Sexton, Paul, Patricia Metcalf, & John Kolbe. (2013). Respiratory Effects of Insulin Sensitisation with Metformin: A Prospective Observational Study. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(2). 133–142. 47 indexed citations
4.
Bilton, Diana, G. Bellon, Brett Charlton, et al.. (2012). Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. Journal of Cystic Fibrosis. 12(4). 367–376. 50 indexed citations
5.
Bilton, Diana, Moira L. Aitken, Patrick A. Flume, et al.. (2011). 78 Combined data from two phase III studies of Bronchitol (inhaled dry powder mannitol) in adult cystic fibrosis (CF) patients. Journal of Cystic Fibrosis. 10. S20–S20. 2 indexed citations
6.
Bilton, Diana, Philip Robinson, Patricia Cooper, et al.. (2010). Phase III study of inhaled dry powder mannitol (Bronchitol™) in cystic fibrosis – results from the 6 and 12 month open label phase. Journal of Cystic Fibrosis. 9. S21–S21. 4 indexed citations
7.
Stevens, Graham, et al.. (2009). Radiotherapy utilisation in lung cancer in New Zealand: disparities with optimal rates explained.. PubMed. 122(1306). 43–54. 8 indexed citations
8.
Stevens, Wendy, et al.. (2009). Lung cancer patients in New Zealand initially present to secondary care through the emergency department rather than by referral to a respiratory specialist.. PubMed. 122(1294). 33–41. 21 indexed citations
9.
Schmid, Jan, Lilan Ling, John Kolbe, et al.. (2008). Pseudomonas aeruginosatransmission is infrequent in New Zealand cystic fibrosis clinics. European Respiratory Journal. 32(6). 1583–1590. 14 indexed citations
10.
Dare, Anna, et al.. (2008). What can the history tell us? An argument for observed history-taking in the trainee intern long case assessment.. PubMed. 121(1282). 51–7. 10 indexed citations
11.
Stevens, Wendy, Graham Stevens, John Kolbe, & Brian Cox. (2008). Ethnic Differences in the Management of Lung Cancer in New Zealand. Journal of Thoracic Oncology. 3(3). 237–244. 50 indexed citations
12.
Stevens, Wendy, Graham Stevens, John Kolbe, & Brian Cox. (2007). Lung Cancer in New Zealand: Patterns of Secondary Care and Implications for Survival. Journal of Thoracic Oncology. 2(6). 481–493. 34 indexed citations
13.
Eaton, T, et al.. (2003). Long-term oxygen therapy improves health-related quality of life. Respiratory Medicine. 98(4). 285–293. 100 indexed citations
14.
Moss‐Morris, Rona, et al.. (2003). The Use of Reliever Medication in Asthma: The Role of Negative Mood and Symptom Reports. Journal of Asthma. 40(4). 357–365. 49 indexed citations
15.
Cameron, Rhoda, John Kolbe, Margaret Wilsher, & Neil Lambie. (2000). Anti-Inflammatory Drugs in Asthma.. Thorax. 55(3). 251d–251. 2 indexed citations
16.
Young, Pamela, et al.. (1999). Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. European Respiratory Journal. 13(4). 855–855. 132 indexed citations
17.
Kolbe, John, et al.. (1999). Community acquired parapneumonic thoracic empyema: Predictors of outcome. Respirology. 4(2). 173–179. 40 indexed citations
18.
Kolbe, John, Wendy Fergusson, & Jeffrey Garrett. (1998). Rapid onset asthma: a severe but uncommon manifestation. Thorax. 53(4). 241–247. 53 indexed citations
19.
Wilsher, Margaret, John Kolbe, Arthur J. Morris, & David Welch. (1997). Nosocomial Acquisition of Burkholderia Gladioli in Patients With Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 155(4). 1436–1440. 25 indexed citations
20.
Vj, Harvey & John Kolbe. (1986). The management of small cell lung cancer.. PubMed. 99(796). 104–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Tiep Breakdown of academic impact, for papers by Tomas Eagan Breakdown of academic impact, for papers by Suzanne C. Lareau Breakdown of academic impact, for papers by Charlotte Suppli Ulrik Breakdown of academic impact, for papers by Anders Løkke Breakdown of academic impact, for papers by G H Koëter Breakdown of academic impact, for papers by Alan Crockett Breakdown of academic impact, for papers by David M. Orenstein Breakdown of academic impact, for papers by Vicente Plaza Breakdown of academic impact, for papers by Fulvio Braido
Rankless by CCL
2026